Controversies: Is There a Role for Positron-Emission Tomographic CT in the Initial Staging of Head and Neck Squamous Cell Carcinoma?

References

1. Bruschini P, Giorgetti A, Bruschini L, et al. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT. Acta Otorhinolaryngol Ital 2003;23:446–53

   PubMed
2. McGuirt WF, Greven K, Williams D 3rd, Keyes JW Jr, et al. PET scanning in head and neck oncology: a review. Head Neck 1998;20:208–15

   CrossRefPubMedWeb of Science
3. Di Martino E, Nowak B, Hassan HA, et al. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 2000;126:1457–61

   PubMedWeb of Science
4. Benchaou M, Lehmann W, Slosman DO, et al. The role of FDG-PET in the preoperative assessment of n-staging in head and neck cancer. Acta Otolaryngol 1996;116:332–35

   CrossRefPubMed
5. Hubner KF, Thie JA, Smith GT, et al. Clinical utility of FDG-PET in detecting head and neck tumors: a comparison of diagnostic methods and modalities. Clin Positron Imaging 2000;3:7–16

   PubMed
6. Dammann F, Horger M, Mueller-Berg M, et al. Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR Am J Roentgenol 2005;184:1326–31

   CrossRefPubMed
7. Halfpenny W, Hain SF, Biassoni L, et al. FDG-PET: a possible prognostic factor in head and neck cancer. Br J Cancer 2002;86:512–16

   CrossRefPubMedWeb of Science
8. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993;34:12–17

   Abstract/FREE Full Text
9. Mukherji SK, Drane WE, Mancuso AA, et al. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT. Radiology 1996;199:761–66

   PubMedWeb of Science
10. Bruschini P, Giorgetti A, Bruschini L, et al. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT. Acta Otorhinolaryngol Ital 2003;23:446–53
11. Wong WL, Chevretton EB, McGurk M, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci 1997;22:209–14
12. Lowe VJ, Dunphy FR, Varvares M, et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 1997;19:666–74

    CrossRefPubMedWeb of Science
13. Delgado-Bolton RC, Fernandez-Perez C, Gonzalez-Mate A, et al. Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med 2003;44:1301–14

    Abstract/FREE Full Text
14. Sheikholeslam-Zadeh R, Choufani G, Goldman S, et al. Unknown primary detected by FDG-PET: a review of the present indications of FDG-PET in head and neck cancers. Acta Otorhinolaryngol Belg 2002;56:77–82

    PubMed
15. Paulino AC, Koshy M, Howell R, et al. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005;61:1385–92

    CrossRefPubMed
16. Schwartz DL, Rajendran J, Yueh B, et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 2004;130:1361–67

    CrossRefPubMedWeb of Science
17. Yao M, Buatti JM, Dornfeld KJ, et al. Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? In regard to Rogers, et al. Int J Radiat Oncol Biol Phys 2004;58:694–97; Int J Radiat Oncol Biol Phys 2005;61:306–307; author reply 307
18. Koshy M, Paulino AC, Howell R, et al. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer. Head Neck 2005;27:494–502

    CrossRefPubMed
19. Nishiyama Y, Yamamoto Y, Yokoe K, et al. FDG PET as a procedure for detecting simultaneous tumours in head and neck cancer patients. Nucl Med Commun 2005;26:239–44

    CrossRefPubMedWeb of Science
20. Branstetter BF 4th, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235:580–86

    PubMedWeb of Science
21. Gutzeit A, Antoch G, Kuhl H, et al. Unknown primary tumors: detection with dual-modality PET/CT: initial experience. Radiology 2005;234:227–34

    PubMedWeb of Science